» Articles » PMID: 27904764

MiR-193b Directly Targets STMN1 and Inhibits the Malignant Phenotype in Colorectal Cancer

Overview
Journal Am J Cancer Res
Specialty Oncology
Date 2016 Dec 2
PMID 27904764
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating evidence suggests that aberrantly expressed microRNAs (miRNAs) contribute to the initiation and progression of human cancers. However, the underlying function of miR-193b in colorectal cancer (CRC) remains largely unexplored. Herein, we demonstrate that miR-193b is significantly down-regulated in CRC tissues compared with their normal counterparts. Kaplan-Meier analysis revealed that decreased miR-193b expression was closely associated with the shorter overall survival of patients with CRC. Through gain-and loss-of-function studies, we showed that miR-193b significantly suppressed CRC cell proliferation and invasion. In addition, bioinformatics analyses and luciferase reporter assays identified Stathmin 1 (STMN1) as the direct functional target of miR-193b in CRC. Furthermore, silencing of STMN1 resulted in a phenotype similar to that observed for overexpression of miR-193b, and restoration of STMN1 expression completely rescued the inhibitory effect of miR-193b in CRC cells. Taken together, our study implies the essential role of miR-193b in negatively regulating CRC progression, and a novel link between miR-193b and STMN1 in CRC.

Citing Articles

Study of KRAS-Related miRNA Expression in Colorectal Cancer.

Wu X, Li Z, Huang N, Li X, Chen R Cancer Manag Res. 2022; 14:2987-3008.

PMID: 36262749 PMC: 9575474. DOI: 10.2147/CMAR.S368551.


MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis.

Yu H, Peng Y, Wu Z, Wang M, Jiang X Transl Cancer Res. 2022; 11(7):2249-2261.

PMID: 35966293 PMC: 9372259. DOI: 10.21037/tcr-21-2557.


MiR-193b-5p inhibits proliferation and enhances radio-sensitivity by downregulating the AKT/mTOR signaling pathway in tongue cancer.

Jiang L, He C, Zhang X, Chen Y, Li G Transl Cancer Res. 2022; 9(3):1851-1860.

PMID: 35117532 PMC: 8799127. DOI: 10.21037/tcr.2020.02.14.


PTEN loss promotes oncogenic function of STMN1 via PI3K/AKT pathway in lung cancer.

Xun G, Hu W, Li B Sci Rep. 2021; 11(1):14318.

PMID: 34253824 PMC: 8275769. DOI: 10.1038/s41598-021-93815-3.


LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression.

Dias F, Almeida C, Teixeira A, Morais M, Medeiros R Biomedicines. 2021; 9(2).

PMID: 33669301 PMC: 7920065. DOI: 10.3390/biomedicines9020195.


References
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

2.
Rotllan N, Price N, Pati P, Goedeke L, Fernandez-Hernando C . microRNAs in lipoprotein metabolism and cardiometabolic disorders. Atherosclerosis. 2016; 246:352-60. PMC: 5357236. DOI: 10.1016/j.atherosclerosis.2016.01.025. View

3.
Zheng P, Liu Y, Chen L, Liu X, Xiao Z, Zhao L . Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer. J Proteome Res. 2010; 9(10):4897-905. DOI: 10.1021/pr100712t. View

4.
Gasque Schoof C, Botelho E, Izzotti A, Dos Reis Vasques L . MicroRNAs in cancer treatment and prognosis. Am J Cancer Res. 2012; 2(4):414-33. PMC: 3410578. View

5.
Liu J, Cao J, Zhao X . miR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1. BMC Urol. 2015; 15:36. PMC: 4423111. DOI: 10.1186/s12894-015-0028-3. View